Coronavirus Patent US 10,130,701 B2

Filed: July 23, 2015 | Application filed by Pirbright Institute¬†| Source Abstract “The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a … Continue reading Coronavirus Patent US 10,130,701 B2